Gary Emmons is a notable inventor based in Washington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating sleep disorders and other medical conditions. With a total of 3 patents to his name, Emmons continues to push the boundaries of innovation in his field.

Latest Patents

One of Gary Emmons' latest patents is focused on the combination of a hypnotic agent and substituted bis aryl and heteroaryl compounds. This invention addresses the need for effective treatments for various sleep disorders. Another significant patent involves sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester. This compound is a metabolite of a 5HT antagonist and is aimed at treating a range of disease states.

Career Highlights

Emmons is currently associated with Aventis Pharmaceuticals Inc., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing therapeutic applications that benefit patients suffering from sleep disorders and other health issues.

Collaborations

Throughout his career, Gary Emmons has collaborated with notable professionals in the field, including Ronald Charles Bernotas and Paul Wayne Brown. These collaborations have contributed to the successful development of his patented inventions.

Conclusion

Gary Emmons stands out as a dedicated inventor whose work in pharmaceuticals has the potential to improve the quality of life for many individuals. His innovative approach and commitment to research continue to drive advancements in therapeutic applications.